Management of Early Node-Positive Breast Cancer in Australia: A Multicentre Study

被引：7

作者：

Gannan, Emma ^{[1
,2
,3
]}

Khoo, Jeremy ^{[4
]}

Nightingale, Sophie ^{[5
]}

Suhardja, Thomas Surya ^{[6
]}

Lippey, Jocelyn ^{[7
]}

Keane, Holly ^{[8
]}

Tan, Kian Jin ^{[9
]}

Clouston, David ^{[4
]}

Gorelik, Alexandra ^{[10
]}

Mann, Gregory Bruce ^{[1
,2
,11
]}

机构：

[1] Royal Melbourne Hosp, Breast Serv, Parkville, Vic, Australia

[2] Royal Womens Hosp, Parkville, Vic, Australia

[3] Royal Melbourne Hosp, Dept Surg, Parkville, Vic, Australia

[4] Focus Pathol, East Melbourne, Vic, Australia

[5] Peter MacCallum Canc Ctr, Dept Surg, East Melbourne, Vic, Australia

[6] Monash Med Ctr, Dept Surg, Clayton, Vic, Australia

[7] Austin Hosp, Dept Surg, Heidelberg, Vic, Australia

[8] Alfred Hosp, Dept Surg, Melbourne, Vic, Australia

[9] St Vincents Hosp Melbourne, Dept Surg, Fitzroy, Vic, Australia

[10] Univ Melbourne, Royal Melbourne Hosp, Melbourne EpiCtr, Parkville, Vic, Australia

[11] Univ Melbourne, Dept Surg, Parkville, Vic, Australia

来源：

BREAST JOURNAL | 2016年 / 22卷 / 04期

关键词：

ACOSOG Z0011 trial; axillary lymph node dissection; breast cancer; sentinel lymph node biopsy; SENTINEL-NODE; AXILLARY DISSECTION; AMERICAN-COLLEGE; CLINICAL-PRACTICE; Z0011; TRIAL; BIOPSY; RECURRENCE; SURGEONS; IMPACT; MICROMETASTASES;

D O I：

10.1111/tbj.12595

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To examine practice patterns for breast cancer patients with limited sentinel node (SN) disease in light of the ACOSOG Z0011 results. Retrospective analysis of patients with T1-2 breast cancer and positive sentinel lymph node biopsy (SLNB) admitted between January 2009 and December 2012. Patient demographics, tumor characteristics, and treatments were recorded. Eight hundred positive SLNBs were identified. A total of 452 (56.5%) proceeded to completion axillary lymph node dissection (cALND). cALND rate decreased from 65.1% to 49.7% from 2009-2010 to 2011-2012. cALND was performed for micrometastasis or isolated tumor cells in 39.3% in 2009-2010 and 22.2% in 2011-2012, whereas for macrometastases the rates were 83.1% and 68.6%, respectively. cALND rates diminished for both Z0011-eligible and -ineligible patients. The ACOSOG Z0011 trial presentation and publication coincided with a reduction in cALND for breast cancer with limited nodal disease. There appears equipoise regarding management of macrometastatic SN disease.

引用

页码：413 / 419

页数：7

共 50 条

[21] Epirubicin for adjuvant therapy in node-positive breast cancer
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2000, 42 (1071): : 12 - 13
[22] PET plus MARI in Node-Positive Breast Cancer
不详
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 16N - 17N
[23] Is axillary lymph node clearance required in node-positive breast cancer?
Bundred, Nigel J.
Barnes, Nicola L. P.
Rutgers, Emiel
Donker, Mila
NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (01) : 55 - 61
[24] Is axillary lymph node clearance required in node-positive breast cancer?
Nigel J. Bundred
Nicola L. P. Barnes
Emiel Rutgers
Mila Donker
Nature Reviews Clinical Oncology, 2015, 12 : 55 - 61
[25] The lymph node ratio as prognostic factor in node-positive breast cancer
Voordeckers, M
Vinh-Hung, V
Van de Steene, J
Lamote, J
Storme, G
RADIOTHERAPY AND ONCOLOGY, 2004, 70 (03) : 225 - 230
[26] Lymph node ratio as prognostic factor in node-positive breast cancer
Storme, G.
Nieto, Y.
Vinh-Hung, V.
Hortobagyi, G.
EJC SUPPLEMENTS, 2005, 3 (02): : 76 - 77
[27] Prognostic Value of Lymph Node Ratio in Node-positive Breast Cancer
Dings, P. J.
Francissen, C. M.
Elferink, M. A.
Strobbe, L. J.
Van Laarhoven, H. W.
De Wilt, J. H.
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S62 - S62
[28] The lymph node ratio as prognostic factor in node-positive breast cancer
Voordeckers, M
Vinh-Hung, V
Van de Steene, J
Lamote, J
Storme, G
RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S243 - S244
[29] Prognostic variables in node-negative and node-positive breast cancer
Gasparini, G
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 321 - 331
[30] Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisal
Chilcott, J.
Jones, M. Lloyd
Wilkinson, A.
HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 7 - 13

← 1 2 3 4 5 →